Acquired resistance to tyrosine kinase inhibitors during cancer therapy
Top Cited Papers
- 1 February 2008
- journal article
- review article
- Published by Elsevier in Current Opinion in Genetics & Development
- Vol. 18 (1), 73-79
- https://doi.org/10.1016/j.gde.2008.01.004
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Protein Kinases as Targets for Cancer TreatmentPharmacogenomics, 2007
- Improved Insight into Resistance Mechanisms to Imatinib in Gastrointestinal Stromal Tumors: A Basis for Novel Approaches and Individualization of TreatmentThe Oncologist, 2007
- Tyrosine Kinase Mutations in Human CancerCurrent Molecular Medicine, 2007
- Small Molecule Tyrosine Kinase Inhibitors in the Treatment of Solid Tumors: An Update of Recent DevelopmentsAnnals of Surgical Oncology, 2006
- Targeted CML therapy: controlling drug resistance, seeking cureCurrent Opinion in Genetics & Development, 2006
- Treating Imatinib-Resistant Leukemia: The Next Generation Targeted TherapiesThe Scientific World Journal, 2006
- Tyrosine Kinases as Targets for Cancer TherapyNew England Journal of Medicine, 2005
- Molecular Targeted Therapy of Lung Cancer: EGFR Mutations and Response to EGFR InhibitorsCold Spring Harbor Symposia on Quantitative Biology, 2005
- Resistance in the land of molecular cancer therapeuticsCancer Cell, 2002
- Molecular mechanisms of resistance to STI571 in chronic myeloid leukemiaCurrent Opinion in Hematology, 2002